Skip to content

CDR

Hello takes oral care on the road

Hello Products announces the launch of its latest innovation, an on-demand mobile service that delivers “everything including the bathroom sink” to busy brushers on the go.

NCPA applauds first of their kind anti-steering laws in Georgia

In a significant victory for Georgia patients and community pharmacists, Gov. Brian Kemp yesterday signed into law two anti- “steering” bills, following significant advocacy by state pharmacists and the Georgia Pharmacy Association. Gov.

IQVIA report notes big drop in opioid dosage volume

The latest report from the IQVIA Institute for Human Data Science found prescription opioid dosage volume — as defined by morphine milligram equivalents, or MMEs — declined 17% in 2018, marking the single-largest annual drop ever recorded within the U.S. market.

Edgewell Personal Care to combine with Harry’s

Edgewell Personal Care Co. and Harry’s Thursday announced that they have entered into a definitive agreement under which Edgewell will combine with Harry’s in a cash and stock transaction that values Harry’s at $1.37 billion.

Perrigo acquires Ranir Global Holdings

Perrigo announced Thursday that it has reached a definitive agreement to purchase privately-held Ranir Global Holdings in a transaction valued at $750 million on a cash-free, debt-free basis, or approximately $685 million net of cash tax benefits on a present value basis.

Drug prices to appear in TV ads

TV commercials for prescription drugs will soon include the price, giving consumers more information upfront to help with medication choices.

Walmart raises minimum age to purchase tobacco to 21

Walmart reported on Wednesday that it will raise the minimum age to buy tobacco products and e-cigarettes at its U.S. stores to 21 amid growing pressure from government agencies to cut tobacco sales and use among minors.

The Relief Products expands PM portfolio

The Relief Products has added to its portfolio of remedies to include PM ointments to provide relief for conditions that tend to worsen at night.

Lupin receives tentative U.S. FDA approval for fosaprepitant for injection

Lupin announced that it has received tentative approval for its fosaprepitant for injection, 150 mg single-dose vial, from the United States Food and Drug Administration (FDA) to market a generic version of Emend for Injection, 150 mg Single-Dose Vial, of Merck Sharp & Dohme Corp. (Merck).